Immunovant

Immunovant is creating therapies for autoimmune diseases. Autoimmune diseases arise when a patient's immune system incorrectly identifies healthy cells as harmful and thus generates autoantibodies. FcRn is a protein receptor that prevents degradation of autoantibodies. Immunovant’s lead product, IMVT-1401, is a human anti-FcRn monoclonal antibody that can be delivered via subcutaneous injection. IMVT-1401 inhibits and enhances degradation of FcRn, thereby allowing degradation of autoantibodies that cause autoimmune disease. Immunovant plans to test IMVT-1401 against a variety of indications, including thyroid eye disease and Myasthenia Gravis.

Jobs:

Site Relationship Manager (US) Central/Mountain We...

Remote|2 days ago

Apply

Site Relationship Manager (US) Mid-Atlantic

Remote|2 days ago

Apply

Senior Director, Program Management

Remote|10 days ago

Apply

Senior Manager, Clinical Quality Assurance (CQA)

Remote|78 days ago

Apply

(Senior) Director, Clinical Operations

Remote|80 days ago

Apply

Director, Data Management

Remote|86 days ago

Apply

Senior Manager, Quality Control

Remote|96 days ago

Apply

Medical Device Engineer, Manager / Senior Manager

Remote|100+ days ago

Apply

Senior Director, Regulatory

Remote|100+ days ago

Apply